BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND GATA3, HDR, 2625, ENSG00000107485, MGC5445, MGC5199, MGC2346 AND Treatment
297 results:

  • 1. Genomic Landscape of Circulating Tumor DNA in Patients With Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Metastatic breast cancer Treated With Abemaciclib: Data From the SCRUM-Japan cancer Genome Screening Project.
    Hattori M; Serelli-Lee V; Naito Y; Yamanaka T; Yasojima H; Nakamura R; Fujisawa T; Imai M; Nakamura Y; Bando H; Kawaguchi T; Yoshino T; Iwata H
    JCO Precis Oncol; 2024 Apr; 8():e2300647. PubMed ID: 38635933
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Deep learning for high-resolution dose prediction in high dose rate brachytherapy for breast cancer treatment.
    Quetin S; Bahoric B; Maleki F; Enger SA
    Phys Med Biol; 2024 Apr; 69(10):. PubMed ID: 38604185
    [No Abstract]    [Full Text] [Related]  

  • 3. Gastric metastasis from breast cancer: five cases and a single-institutional review.
    Cheng M; Jia Z; Zhang G; Wang Y; Li S; Yang S; Li C; Geng C
    J Int Med Res; 2024 Mar; 52(3):3000605241233988. PubMed ID: 38483129
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Circulating tumor DNA for predicting recurrence in patients with operable breast cancer: a systematic review and meta-analysis.
    Nader-Marta G; Monteforte M; Agostinetto E; Cinquini M; Martins-Branco D; Langouo M; Llombart-Cusac A; Cortés J; Ignatiadis M; Torri V; Apolone G; Cappelletti V; Pruneri G; de Azambuja E; Di Cosimo S
    ESMO Open; 2024 Mar; 9(3):102390. PubMed ID: 38460249
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical sequencing defines the somatic and germline mutation landscapes of Chinese HER2-Low breast cancer.
    Han BY; Chen C; Luo H; Lin CJ; Han XC; Nasir J; Shi JX; Huang W; Shao ZM; Ling H; Hu X
    Cancer Lett; 2024 Apr; 588():216763. PubMed ID: 38403109
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Whole-Genome Sequencing Analysis of Male breast cancer Unveils Novel Structural Events and Potential Therapeutic Targets.
    Al Assaad M; Michaud O; Semaan A; Sigouros M; Tranquille M; Phan A; Levine MF; Gundem G; Medina-Martínez JS; Papaemmanuil E; Manohar J; Wilkes D; Sboner A; Hoda SAF; Elemento O; Mosquera JM
    Mod Pathol; 2024 Apr; 37(4):100452. PubMed ID: 38369186
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. A Metabolic-Epigenetic Mechanism Directs Cell Fate and Therapeutic Sensitivity in breast cancer.
    Bernard MJ; Goldstein AS
    Cancer Res; 2024 May; 84(9):1382-1383. PubMed ID: 38330100
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China.
    Ren M; Cai X; Jia L; Bai Q; Zhu X; Hu X; Wang Q; Luo Z; Zhou X
    BMC Cancer; 2023 Dec; 23(1):1175. PubMed ID: 38041048
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genome editing approaches with CRISPR/Cas9: the association of NOX4 expression in breast cancer patients and effectiveness evaluation of different strategies of CRISPR/Cas9 to knockout Nox4 in cancer cells.
    Javadi M; Sazegar H; Doosti A
    BMC Cancer; 2023 Nov; 23(1):1155. PubMed ID: 38012557
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. treatments During Pregnancy Targeting ERBB2 and Outcomes of Pregnant Individuals and Newborns.
    Gougis P; Grandal B; Jochum F; Bihan K; Coussy F; Barraud S; Asselain B; Dumas E; Sebbag C; Hotton J; Spaggiari E; Pierga JY; Savarino R; Laas E; Spano JP; Reyal F; Hamy AS
    JAMA Netw Open; 2023 Oct; 6(10):e2339934. PubMed ID: 37883083
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Architecture and topologies of gene regulatory networks associated with breast cancer, adjacent normal, and normal tissues.
    Kumar S; Vindal V
    Funct Integr Genomics; 2023 Oct; 23(4):324. PubMed ID: 37878223
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Novel Form of breast Intraoperative Radiation Therapy with CT-Guided High-Dose-Rate Brachytherapy: Interim Results of a Prospective Phase-II Clinical Trial.
    Turkheimer LM; Petroni GR; Berger AC; Schroen AT; Brenin DR; Lazar M; Libby B; Janowski EM; Showalter TN; Showalter SL
    J Am Coll Surg; 2024 Jan; 238(1):10-20. PubMed ID: 37870228
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Solid-Basaloid Adenoid Cystic Carcinoma of the breast: An Aggressive Subtype Enriched for Notch Pathway and Chromatin Modifier Mutations With MYB Overexpression.
    Shamir ER; Bean GR; Schwartz CJ; Vohra P; Wang A; Allard GM; Wolsky RJ; Garcia JJ; Chen YY; Krings G
    Mod Pathol; 2023 Dec; 36(12):100324. PubMed ID: 37660928
    [TBL] [Abstract] [Full Text] [Related]  

  • 14.
    Petoukhova A; Snijder R; Vissers T; Ceha H; Struikmans H
    Phys Med Biol; 2023 Sep; 68(18):. PubMed ID: 37607566
    [No Abstract]    [Full Text] [Related]  

  • 15. The mutational landscape of a US Midwestern breast cancer cohort reveals subtype-specific cancer drivers and prognostic markers.
    Vellichirammal NN; Tan YD; Xiao P; Eudy J; Shats O; Kelly D; Desler M; Cowan K; Guda C
    Hum Genomics; 2023 Jul; 17(1):64. PubMed ID: 37454130
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Genomics of
    Lipsyc-Sharf M; Jain E; Collins LC; Rosenberg SM; Ruddy KJ; Tamimi RM; Schapira L; Come SE; Peppercorn JM; Borges VF; Warner E; Snow C; Krop IE; Kim D; Weiss J; Zanudo JGT; Partridge AH; Wagle N; Waks AG
    JCO Precis Oncol; 2023 Jun; 7():e2300076. PubMed ID: 37364233
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. gata3 mediates doxorubicin resistance by inhibiting CYB5R2-catalyzed iron reduction in breast cancer cells.
    Zhu Z; Shen H; Xu J; Fang Z; Wo G; Ma Y; Yang K; Wang Y; Yu Q; Tang JH
    Drug Resist Updat; 2023 Jul; 69():100974. PubMed ID: 37230023
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A MC-based anthropomorphic test case for commissioning model-based dose calculation in interstitial breast 192-Ir hdr brachytherapy.
    Peppa V; Thomson RM; Enger SA; Fonseca GP; Lee C; Lucero JNE; Mourtada F; Siebert FA; Vijande J; Papagiannis P
    Med Phys; 2023 Jul; 50(7):4675-4687. PubMed ID: 37194638
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Pentoxifylline changes the balance of immune cell population in breast tumor-infiltrating lymphocytes.
    Kazemi MH; Shokrollahi Barough M; Momeni-Varposhti Z; Ghanavatinejad A; Zarehzadeh Mehrabadi A; Sadeghi B; Falak R
    Med Oncol; 2023 May; 40(6):168. PubMed ID: 37149505
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Profiling the Somatic Mutational Landscape of breast Tumors from Hispanic/Latina Women Reveals Conserved and Unique Characteristics.
    Ding YC; Song H; Adamson AW; Schmolze D; Hu D; Huntsman S; Steele L; Patrick CS; Tao S; Hernandez N; Adams CD; Fejerman L; Gardner K; Nápoles AM; Pérez-Stable EJ; Weitzel JN; Bengtsson H; Huang FW; Neuhausen SL; Ziv E
    Cancer Res; 2023 Aug; 83(15):2600-2613. PubMed ID: 37145128
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 15.